SIG-001 (Signature Biologics/ Arugula Sciences)

N/A

Report date: 2025/06/11 10:49:28

Base Information

Drug NameSIG-001 (Signature Biologics/ Arugula Sciences)
Drug Alias Namesignature cord prime (Signature Biologics)umbilical cord tissue allograft (Signature Biologics/ Arugula Sciences)SIG-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionStem cells modulators
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSignature Biologics LLC
China Registration ClassN/A

Develop Information

Active CompaniesArugula Sciences LLCSignature Biologics LLC
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A